{"product_id":"5th-annual-cedars-sinai-gastrointestinal-tumor-conference-2024","title":"5th Annual Cedars-Sinai Gastrointestinal Tumor Conference 2024","description":"The 5th Annual Cedars-Sinai Gastrointestinal Tumor Conference will provide concise and comprehensive updates on the most recent research and advances in therapy for gastrointestinal cancers. A stellar faculty has been assembled to share developments in precision medicine, research, and immunotherapeutic approaches to the treatment of cancers of the pancreas, liver, and gastric\/esophagus.\u003cbr\u003e\u003cbr\u003e \u003cbr\u003e\u003cbr\u003e\u003cstrong\u003e Include: 2 videos + 10 pdfs, size: 3.88 GB\u003c\/strong\u003e\n\u003cbr\u003e\u003cstrong\u003e+ Target Audience: Endocrinology \u0026amp; Metabolism, Family \/ General Medicine, Gastroenterology, Hepatology, Internal Medicine physician\u003c\/strong\u003e\u003cbr\u003e\u003cbr\u003e \u003cbr\u003e\u003cbr\u003e\u003cstrong\u003e+ Information:\u003c\/strong\u003e\n\u003cbr\u003e\u003cdiv class=\"form-group\"\u003e\n\u003cdiv class=\"form-control-plaintext\"\u003e\n\u003cdiv class=\"form-group\"\u003e\n\u003cdiv class=\"activitysectionbold\"\u003eDate \u0026amp; Location\u003c\/div\u003e\n\u003cbr\u003eSaturday, March 23, 2024, 7:30 AM – 12:30 PM PST, Cedars-Sinai Harvey Morse Conference Center, Los Angeles, CA\u003cbr\u003e\u003ch2 class=\"activitysectionbold\"\u003eTarget Audience\u003c\/h2\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003e\n\u003cem\u003eSpecialties\u003c\/em\u003e – Endocrinology \u0026amp; Metabolism, Family \/ General Medicine, Gastroenterology, Hepatology, Internal Medicine, Medical Genetics, Nuclear Medicine, Oncology, Pain Management, Palliative Care, Pathology \u0026amp; Laboratory Medicine, Radiation Oncology, Radiology\u003c\/div\u003e\n\u003cdiv\u003e\n\u003cem\u003eProfessions\u003c\/em\u003e – Nurse (Advanced Practice NP CRNA CNM CNS), Other (non-physician), Physician\u003c\/div\u003e\n\u003cbr\u003e \u003cbr\u003e\u003ch3 class=\"activitysectionbold\"\u003eOverview\u003c\/h3\u003e\n\u003cbr\u003eThe 5th Annual Cedars-Sinai Gastrointestinal Tumor Conference will provide concise and comprehensive updates on the most recent research and advances in therapy for gastrointestinal cancers. A stellar faculty has been assembled to share developments in precision medicine, research, and immunotherapeutic approaches to the treatment of cancers of the pancreas, liver, and gastric\/esophagus.\u003cbr\u003e\u003cbr\u003eInvited faculty will present a comprehensive bench to bedside review of immune therapy for GI malignancies, detail immune therapies for pancreatic cancer, and explore advances in biomarkers and immunotherapy in gastroesophageal cancers. Biomarker strategies for neuroendocrine and rare tumors will be presented and participants will also have an opportunity to review immune-related toxicities. Join your colleagues for this important half day educational activity that will enhance your understanding of GI cancers and provide you with valuable information to inform your clinical decision-making and treatment approaches for your patients.\u003cbr\u003e\u003ch3 class=\"activitysectionbold\"\u003eObjectives\u003c\/h3\u003e\n\u003col\u003e\n\u003cli\u003eConsider advances in biomarkers and therapy to better inform treatment decision-making for patients with gastroesophageal cancers\u003c\/li\u003e\n\u003cli\u003eUse AJCC or other appropriate staging in clinical practice, including the use of appropriate prognostic indicators and evidence-based national guidelines for treatment planning\u003c\/li\u003e\n\u003cli\u003eEvaluate the basic science of immune therapy for GI malignancies and the implications for transfer from bench to bedside\u003c\/li\u003e\n\u003cli\u003eIncrease knowledge of therapy for neuroendocrine tumors and biomarker identification of novel therapies\u003c\/li\u003e\n\u003cli\u003eIdentify and implement optimal strategies for managing therapy-related side effects and toxicities in patients treated with therapeutic agents\u003c\/li\u003e\n\u003cli\u003eAnticipate the needs, problems, and issues of cancer survivors and develop an individualized wellness plan in partnership with cancer survivors, their families and the healthcare team\u003c\/li\u003e\n\u003c\/ol\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e \u003cbr\u003e\u003cbr\u003e \u003cbr\u003e\u003cbr\u003e\u003cstrong\u003e+Topics:\u003c\/strong\u003e\u003cbr\u003e\u003cbr\u003e*Note: these are continuous video recordings during the conference, they include individual lectures mentioned in the Detail section below\u003cbr\u003e\u003cul\u003e\n\u003cli\u003eAgenda.pdf\u003c\/li\u003e\n\u003cli\u003eCedars Sinai Cancer- Molecular Twin.pdf\u003c\/li\u003e\n\u003cli\u003eCholangiocarcinoma and HCC.pdf\u003c\/li\u003e\n\u003cli\u003eHow I approach TNT in Rectal Cancer.pdf\u003c\/li\u003e\n\u003cli\u003eImmunotherapy for GI Cancer.pdf\u003c\/li\u003e\n\u003cli\u003eManagment updates in Neuroendocrine tumors 2024.pdf\u003c\/li\u003e\n\u003cli\u003eMarch 23 Part 1.mp4\u003c\/li\u003e\n\u003cli\u003eMarch 23 Part 2.mp4\u003c\/li\u003e\n\u003cli\u003eMolecular Landscape in CRC- Shaping the Future.pdf\u003c\/li\u003e\n\u003cli\u003eRole of Social Media in Oncology Today.pdf\u003c\/li\u003e\n\u003cli\u003eThe Challenges of Treating Pancreatic Cancer.pdf\u003c\/li\u003e\n\u003cli\u003eUpdate in Surgical Management of Gastric Cancer.pdf\u003c\/li\u003e\n\u003c\/ul\u003e\u003cbr\u003e \u003cbr\u003e\u003ch3\u003e*Detail:\u003c\/h3\u003e\n\u003ch3 class=\"boxAgendaTitle\"\u003eSaturday, March 23, 2024\u003c\/h3\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"12u\"\u003e\n\u003cdiv class=\"boxAgenda agendaBlue\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cul\u003e\n\u003cli class=\"10u\"\u003e\n\u003cstrong\u003eIntroduction\u003c\/strong\u003e\u003cbr\u003e8:00AM – 8:05AM\u003cbr\u003eAndrew E Hendifar, MD\u003cbr\u003eArsen Osipov, MD\u003cbr\u003eJun Gong, MD\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda agendaBlue\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cul\u003e\n\u003cli class=\"10u\"\u003e\n\u003cstrong\u003eMolecular Landscape in CRC: Shaping the Future\u003c\/strong\u003e\u003cbr\u003e8:05AM – 8:25AM\u003cbr\u003eMarwan Fakih, MD\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda agendaBlue\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cul\u003e\n\u003cli class=\"10u\"\u003e\n\u003cstrong\u003eThe Challenges of Treating Pancreatic Cancer\u003c\/strong\u003e\u003cbr\u003e8:25AM – 8:45AM\u003cbr\u003ePhilip Philip, MD\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda agendaBlue\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cul\u003e\n\u003cli class=\"10u\"\u003e\n\u003cstrong\u003eCholangiocarcinoma and HCC\u003c\/strong\u003e\u003cbr\u003e8:45AM – 9:05AM\u003cbr\u003eAnthony El-Khoueiry, MD\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda agendaBlue\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cul\u003e\n\u003cli class=\"10u\"\u003e\n\u003cstrong\u003eUpdate in Surgical Management of Gastric Cancer\u003c\/strong\u003e\u003cbr\u003e9:05AM – 9:25AM\u003cbr\u003eMiguel Burch, MD\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda agendaBlue\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cul\u003e\n\u003cli class=\"10u\"\u003e\n\u003cstrong\u003ePanel Discussion: GI Cancer Cases\u003c\/strong\u003e\u003cbr\u003e9:25AM – 9:45AM\u003cbr\u003eAnthony El-Khoueiry, MD\u003cbr\u003eEdward Wolin, MD\u003cbr\u003ePhilip Philip, MD\u003cbr\u003eEmily Nachtigal, MD (Panelist)\u003cbr\u003eVi K. Chiu, MD, PhD (Panelist)\u003cbr\u003eKambiz Kosari, MD\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda agendaBlue\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cul\u003e\n\u003cli class=\"10u\"\u003e\n\u003cstrong\u003eBreak and Exhibits\u003c\/strong\u003e\u003cbr\u003e9:45AM – 10:05AM\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda agendaBlue\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cul\u003e\n\u003cli class=\"10u\"\u003e\n\u003cstrong\u003eNovel approaches to targeting amino acid metabolism and the PI3K pathway in cancer\u003c\/strong\u003e\u003cbr\u003e10:05AM – 10:25AM\u003cbr\u003eOliver DK Maddocks, MPharm, PhD\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda agendaBlue\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cul\u003e\n\u003cli class=\"10u\"\u003e\n\u003cstrong\u003eCedars Sinai Cancer: Molecular Twin\u003c\/strong\u003e\u003cbr\u003e10:25AM – 10:45AM\u003cbr\u003eDan Theodorescu, MD, PhD\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda agendaBlue\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cul\u003e\n\u003cli class=\"10u\"\u003e\n\u003cstrong\u003eHow I approach TNT in Rectal Cancer\u003c\/strong\u003e\u003cbr\u003e10:45AM – 11:05AM\u003cbr\u003eKatelyn Atkins, MD, PhD\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda agendaBlue\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cul\u003e\n\u003cli class=\"10u\"\u003e\n\u003cstrong\u003eManagment updates in Neuroendocrine tumors 2024\u003c\/strong\u003e\u003cbr\u003e11:05AM – 11:25AM\u003cbr\u003eEdward Wolin, MD\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda agendaBlue\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cul\u003e\n\u003cli class=\"10u\"\u003e\n\u003cstrong\u003ePick Up Lunch and Exhibits\u003c\/strong\u003e\u003cbr\u003e11:25AM – 11:45AM\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda agendaBlue\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cul\u003e\n\u003cli class=\"10u\"\u003e\n\u003cstrong\u003eImmunotherapy for GI Cancer\u003c\/strong\u003e\u003cbr\u003e11:45AM – 12:05PM\u003cbr\u003eJoel R Hecht, MD\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda agendaBlue\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cul\u003e\n\u003cli class=\"10u\"\u003e\n\u003cstrong\u003eRole of Social Media in Oncology Today\u003c\/strong\u003e\u003cbr\u003e12:05PM – 12:25PM\u003cbr\u003eTatiana Prowell, MD\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda agendaBlue\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cul\u003e\n\u003cli class=\"10u\"\u003e\n\u003cstrong\u003eClosing Remarks\u003c\/strong\u003e\u003cbr\u003e12:25PM – 12:30PM\u003cbr\u003eAndrew E Hendifar, MD\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"meducours","offers":[{"title":"Default Title","offer_id":42954379788386,"sku":"MED-AMB02223","price":15.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0662\/9549\/6802\/files\/Cedars-Sinai-5th-Annual-Cedars-Sinai-Gastrointestinal-Tumor-Conference-2024.png?v=1779374928","url":"https:\/\/meducourse.com\/products\/5th-annual-cedars-sinai-gastrointestinal-tumor-conference-2024","provider":"Meducourse","version":"1.0","type":"link"}